North America Hypodermic Needles Market Size, Share & Industry Trends Analysis Report By Product (Safety and Non-safety), By Application, By End Users, By Country and Growth Forecast, 2022 - 2028
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the North America Hypodermic Needles Market
Market Report Description
The North America Hypodermic Needles Market would witness market growth of 2.7% CAGR during the forecast period (2022-2028).
As many patients with diabetes have to inject daily doses of insulin into their bodies by themselves, manufacturers are designing less painful injection needles. Smaller needles are becoming more popular as a result of a desire to provide less painful medical needles, and manufacturers are responding to this demand of their consumers. In the medical field, progress is being made as doctors and specialists discover that inserting tiny needles into the skin is easier and more trustworthy. Hence, these manufacturers are also increasing their investments in the production of minimally invasive and less painful needles this factor would play a major role in accelerating the growth of the hypodermic needles market.
In order to fulfill the high degree of quality in materials and accurately administer pharmaceuticals, hypodermic needle producers have become accustomed to meeting ISO criteria. The constant demand for syringes has forced enterprises to implement automated inspection and testing methods. During industrial operations, optical and vision technologies are utilized to verify random samples. In the hypodermic needles market, surface polish, visual appeal, and cleanliness are forming as essential requirements. Manufacturers are ramping up the manufacturing of safety hypodermic needles that are meticulously manufactured to meet the demands of clinicians and ensure patient comfort. The patented, dependable hinged sheath design gives audible, visible, and tactile confirmation of pharmaceutical safety during administration.
The Canadian healthcare system was founded on the concept that access to health care should be based on requirements rather than the ability to pay. In 1947, Medicare was established in one province. It was subsequently harmonized through criteria in a federal statute, the Canada Health Act of 1984, and disseminated across the country through federal cost-sharing. The healthcare system is more of a decentralized collection of territorial and provincial insurance plans covering a limited set of services that are provided free at the point of care than a truly national system. Long waits for elective care necessitate the capacity and willingness to scale up sustainable and effective care delivery methods across the country, given the country's geographic and population diversity. If health imbalances encountered by Indigenous peoples and some vulnerable groups are to be effectively addressed, concerted action on social determinants of health is also required. The restoration of the tripartite social compact among healthcare providers, governments, and the public is required to achieve the great objectives of Medicare's creators.
The US market dominated the North America Hypodermic Needles Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $842.2 million by 2028. The Canada market is anticipated to grow at a CAGR of 5% during (2022 - 2028). Additionally, The Mexico market would showcase a CAGR of 4.1% during (2022 - 2028).
Based on Product, the market is segmented into Safety and Non-safety. Based on Application, the market is segmented into Drug Delivery, Vaccination and Blood Specimen Collection. Based on End Users, the market is segmented into Hospital, Diabetic Patients, Family Practitioners, Psychiatry and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Hypodermic Needles Market is Predict to reach $4.2 Billion by 2028, at a CAGR of 3.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Terumo Corporation, Nipro Corporation, Cardinal Health, Inc., B. Braun Melsungen AG, McKesson Corporation, Retractable Technologies, Inc., Connecticut Hypodermics, Inc., Exelint International, Co., and i-Tech Medics Private Limited.
Scope of the Study
Market Segments Covered in the Report:
- Safety and
- Drug Delivery
- Blood Specimen Collection
By End User
- Diabetic Patients
- Family Practitioners
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Becton, Dickinson and Company
- Terumo Corporation
- Nipro Corporation
- Cardinal Health, Inc.
- B. Braun Melsungen AG
- McKesson Corporation
- Retractable Technologies, Inc.
- Connecticut Hypodermics, Inc.
- Exelint International, Co.
- Hi-Tech Medics Private Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free